Br J Clin Pharmacol. 2018 Jun 2. doi: 10.1111/bcp.13657.
[Epub ahead of print]
Abstract
During the last decade we are witnessing a rise in medical cannabis use, yet the evidence for the safety and effectiveness of the different cannabinoid compounds is scarce. We believe that the role of the clinical research community is to identify the potential benefit of the new compounds under the Evidence Based Medicine paradigm. In this editorial review we shall present a summary of selected evidence of safety and efficacy of cannabis derived products with an emphasis on prospective studies in Israel.
- PMID: 29859014
- DOI: 10.1111/bcp.13657
-
Publication type